临床肝胆病杂志2018，Vol.34Issue(6)：1313-1317,5.DOI:10.3969/j.issn.1001-5256.2018.06.039
老年肝细胞癌患者的治疗现状
Current status of treatment of primary hepatocellular carcinoma in the elderly population
黄永杰 1吴德全 1苑俊辉1
作者信息
- 1. 哈尔滨医科大学附属第二医院,哈尔滨150001
- 折叠
摘要
Abstract
With the global aging, the incidence rate of HCC in the elderly population is gradually increasing , and thus it has become a global health issue.With reference to relevant literature, this article analyzes the clinical features of elderly HCC patients and reviews the current status of therapies and clinical outcomes .The review of clinical outcomes is mainly based on the comparison of therapeutic outcome between elderly and non -elderly HCC patients in many countries and regions in the world .This article points out that elderly HCC patients have their own clinical features, and since elderly HCC patients often have other diseases , such as diabetes, renal failure, and lung and cardiovascular diseases, there is an increase in the risk of treatment, but they often have positive treatment outcomes .With the deepening of research and the improvement of various treatment methods , the therapeutic outcome of elderly HCC patients will also be improved .Therefore,positive attitude and strategies should be adopted in the clinical treatment of elderly HCC patients .关键词
癌,肝细胞/治疗/老年人/综述Key words
carcinoma/hepatocellular/therapy/aged/review分类
医药卫生引用本文复制引用
黄永杰,吴德全,苑俊辉..老年肝细胞癌患者的治疗现状[J].临床肝胆病杂志,2018,34(6):1313-1317,5.
